DOC PREVIEW
Mild Cognitive Impairment

This preview shows page 1-2 out of 7 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 7 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 7 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 7 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

Fax +41 61 306 12 34E-Mail [email protected] Original Research Article Dement Geriatr Cogn Disord 2010;30:238–244 DOI: 10.1159/000320137 Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment DeidreJ.Devier  a NicoleVillemarette-Pittman  a PatrickBrown  b,c GregoryPelton  b,c YaakovStern  b,c MarySano  d,e D.P.Devanand  b,c  a  Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, La. , b  Division of Geriatric Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, c  Department of Neurology, Sergievsky Center, Taub Institute for Research in Alzheimer’s Disease and the Aging Brain, and d  Department of Psychiatry, and Alzheimer’s Disease Research Center, Mount Sinai School of Medicine, New York, N.Y. , and e  Department of Neurology, James J. Peters VA Medical Center, Bronx, N.Y. , USA Introduction Mild cognitive impairment (MCI) is often a transi-tional stage between age-related memory decline andAlzheimer’s disease (AD) [1, 2] , though many individuals with MCI remain cognitively stable. Identifying the earli-est symptoms and their relative temporal onset may help to improve early diagnosis, estimate prognosis and even-tually impact treatment. Efforts have been made to stan-dardize methods of determining the date of onset and the types of symptoms present [3–7] . Symptoms appear well before one seeks treatment, and clarifying that time course by the employment of thorough interview tech-niques yields reliable findings [7] . Although memory de-cline is often the first symptom identified, other symp-toms may also be the earliest to appear. Oppenheim [3] found in a retrospective review of patients diagnosed with AD that about half of them reported early changes in psychiatric, neurological and functional modalities. Kang et al. [8] interviewed caregivers of persons with AD and found that, in addition to memory decline, changes in orientation, judgment, depression and language pre-ceded diagnosis. Key Words Age at onset ⴢ Alzheimer’s disease ⴢ Behavioral symptoms ⴢ Mild cognitive impairment ⴢ Neuropsychological assessment Abstract Background/Aims: To assess (1) the duration and symptoms present in participants with mild cognitive impairment (MCI) and (2) the impact of these variables on predicting conver-sion to Alzheimer’s disease (AD). Methods: Participants with MCI (n = 148) were assessed and followed systematically. Re-sults: Decline in memory was reported as the first symptom in 118 of the cases. Converters had more symptoms (e.g. lan-guage decline, depression), and the combination of decline in memory and in performance of high-order social/cogni-tive activities as well as disorientation more often than non-converters (p = 0.036). In an age-stratified Cox model, predic-tors of conversion to AD were shorter time since onset of memory decline and lower baseline MMSE score. Conclu-sions: Recent onset of memory decline with older age, de-creased MMSE score, change in performance and disorienta-tion indicate a greater likelihood of short-term conversionto AD. Copyright © 2010 S. Karger AG, Basel Accepted: August 6, 2010 Published online: September 15, 2010 Deidre J. Devier, PhD Department of Neurology, Louisiana State University Health Sciences Center 1542 Tulane Avenue, Floor 7 New Orleans, LA 70112 (USA) Tel. +1 504 939 8906, Fax +1 504 285 8078, E-Mail ddevie  @  lsuhsc.edu © 2010 S. Karger AG, Basel Accessible online at:www.karger.com/demOnset of Illness in MCI Dement Geriatr Cogn Disord 2010;30:238–244239 In the development of the ‘Onset of Illness Interview’, our group used a standardized semistructured inter-view to assess time of onset of specific domains of symp-toms, and tested it with informants of 36 individuals with dementia [4] . Open-ended questions about the first iden tified symptom referenced calendar dates and as-sisted informants to recall sa lient personal events to pin-point specific occurrences. The interview format also helped informants identify the date when that symptom was not present [4] . This semistructured interview pro-cess showed good interrater and interinformant reliabil-ity [4] and has been used effectively in other studies [8–12] . In addition to the reliability of the semistructured interview, there is a considerable literature to suggest that eliciting information from informants is more reli-able than self-report in patients with MCI or AD [13 –18] . In this study that examined several predictors of con-version from MCI to AD, the Onset of Illness Interview [4] was administered to the informants of patients who presented with cognitive impairment, but not dementia. The type of informant-reported symptoms present at ill-ness onset and the duration of these symptoms from on-set to study entry were also examined as predictors of conversion to AD. We hypothesized that a greater num-ber of early symptoms and a shorter time course of these symptoms would be associated with a quicker conver-sion to AD. In addition, we planned to explore the rela-tionship between early informant-reported symptoms and objectively measured baseline cognitive perfor-mance. Materials and Methods Participants Patients presented with memory complaints to either the Memory Disorders Clinic or the Center for Memory and Behav-ioral Disorders at the New York State Psychiatric Institute/Co-lumbia University. All participants met study criteria for cogni-tive impairment without dementia and provided informed con-sent in this New York State Psychiatric Institute/Columbia University institutional-review-board-approved protocol. Eligibility Criteria Inclusion criteria identified a wide group of cognitively im-paired individuals, aged 41–85 years, with memory complaints and without dementia with onset of cognitive impairment be-tween 6 months and 10 years prior to enrollment, and Folstein MMSE scores of 6 22/30 [19] . Cognitive screening inclusion guidelines were described previously [20] and included Folstein MMSE recall of ^ 2/3 objects at 5 min, or a Buschke Selective Re-minding Test delayed recall score 1 1 SD below norms, or a Wechsler Adult Intelligence Scale-Revised performance IQ score 6 10 points


Mild Cognitive Impairment

Download Mild Cognitive Impairment
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Mild Cognitive Impairment and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Mild Cognitive Impairment 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?